Global Sodium Valproate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium Valproate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
Sodium Valproate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Valproate market is projected to reach US$ 252.5 million in 2029, increasing from US$ 167 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2029. Demand from Epilepsy and Migraines are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Valproate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Valproate key manufacturers include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc. Sanofi, AbbVie, Athenex are top 3 players and held % sales share in total in 2022.
Sodium Valproate can be divided into Injection, Tablet and Liquid,, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Valproate is widely used in various fields, such as Epilepsy, Migraines and Others,, etc. Epilepsy provides greatest supports to the Sodium Valproate industry development. In 2022, global % sales of Sodium Valproate went into Epilepsy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Valproate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Segment by Type
Injection
Tablet
Liquid
Epilepsy
Migraines
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Valproate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Valproate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Valproate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Valproate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Valproate introduction, etc. Sodium Valproate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Sodium Valproate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Sodium Valproate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Valproate market is projected to reach US$ 252.5 million in 2029, increasing from US$ 167 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2029. Demand from Epilepsy and Migraines are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Valproate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Valproate key manufacturers include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc. Sanofi, AbbVie, Athenex are top 3 players and held % sales share in total in 2022.
Sodium Valproate can be divided into Injection, Tablet and Liquid,, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Valproate is widely used in various fields, such as Epilepsy, Migraines and Others,, etc. Epilepsy provides greatest supports to the Sodium Valproate industry development. In 2022, global % sales of Sodium Valproate went into Epilepsy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Valproate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Segment by Type
Injection
Tablet
Liquid
Segment by Application
Epilepsy
Migraines
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Valproate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Valproate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Valproate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Valproate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Valproate introduction, etc. Sodium Valproate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Sodium Valproate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.